nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Solifenacin—Hypertension—Vincristine—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Solifenacin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Solifenacin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Solifenacin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Solifenacin—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Solifenacin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Solifenacin—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00136	0.00136	CcSEcCtD
Solifenacin—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Solifenacin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Solifenacin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Solifenacin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Solifenacin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Solifenacin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Solifenacin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Solifenacin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Solifenacin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Solifenacin—Infection—Vincristine—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Solifenacin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Solifenacin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Solifenacin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Solifenacin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Solifenacin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Solifenacin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Solifenacin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00129	0.00129	CcSEcCtD
Solifenacin—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Solifenacin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Solifenacin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Solifenacin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Solifenacin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Solifenacin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Solifenacin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Solifenacin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Solifenacin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Solifenacin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Solifenacin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Solifenacin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Solifenacin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Solifenacin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Solifenacin—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Solifenacin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Solifenacin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Solifenacin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Solifenacin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Solifenacin—Infection—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Solifenacin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Solifenacin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Rash—Topotecan—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Cough—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Solifenacin—Headache—Topotecan—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Solifenacin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Constipation—Vincristine—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Rash—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Solifenacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Solifenacin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Solifenacin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Solifenacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Solifenacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Solifenacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Solifenacin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Solifenacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Solifenacin—Infection—Etoposide—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Solifenacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Solifenacin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Solifenacin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Solifenacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Solifenacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Solifenacin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Solifenacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Solifenacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000997	0.000997	CcSEcCtD
Solifenacin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Solifenacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000985	0.000985	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000977	0.000977	CcSEcCtD
Solifenacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Solifenacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000971	0.000971	CcSEcCtD
Solifenacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Solifenacin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000953	0.000953	CcSEcCtD
Solifenacin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000949	0.000949	CcSEcCtD
Solifenacin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000942	0.000942	CcSEcCtD
Solifenacin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000942	0.000942	CcSEcCtD
Solifenacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Solifenacin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Solifenacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Solifenacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000926	0.000926	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000925	0.000925	CcSEcCtD
Solifenacin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000924	0.000924	CcSEcCtD
Solifenacin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Solifenacin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.000914	CcSEcCtD
Solifenacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000908	0.000908	CcSEcCtD
Solifenacin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000891	0.000891	CcSEcCtD
Solifenacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Solifenacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Solifenacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000876	0.000876	CcSEcCtD
Solifenacin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Solifenacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000873	0.000873	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Solifenacin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.000866	CcSEcCtD
Solifenacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Solifenacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000862	0.000862	CcSEcCtD
Solifenacin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.000857	CcSEcCtD
Solifenacin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000851	0.000851	CcSEcCtD
Solifenacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000847	0.000847	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000847	0.000847	CcSEcCtD
Solifenacin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000841	0.000841	CcSEcCtD
Solifenacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000839	0.000839	CcSEcCtD
Solifenacin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000839	0.000839	CcSEcCtD
Solifenacin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000835	0.000835	CcSEcCtD
Solifenacin—Rash—Vincristine—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Solifenacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Solifenacin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000833	0.000833	CcSEcCtD
Solifenacin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000831	0.000831	CcSEcCtD
Solifenacin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Solifenacin—Headache—Vincristine—peripheral nervous system neoplasm	0.000829	0.000829	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000824	0.000824	CcSEcCtD
Solifenacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000815	0.000815	CcSEcCtD
Solifenacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000799	0.000799	CcSEcCtD
Solifenacin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Solifenacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00079	0.00079	CcSEcCtD
Solifenacin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000786	0.000786	CcSEcCtD
Solifenacin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000785	0.000785	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000776	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000773	0.000773	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Solifenacin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.000769	CcSEcCtD
Solifenacin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000767	0.000767	CcSEcCtD
Solifenacin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000764	0.000764	CcSEcCtD
Solifenacin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Solifenacin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000758	0.000758	CcSEcCtD
Solifenacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
Solifenacin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000741	0.000741	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Solifenacin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000738	0.000738	CcSEcCtD
Solifenacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000737	0.000737	CcSEcCtD
Solifenacin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000736	0.000736	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000731	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000726	0.000726	CcSEcCtD
Solifenacin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000721	0.000721	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Solifenacin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000709	0.000709	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000707	0.000707	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000705	CcSEcCtD
Solifenacin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000695	0.000695	CcSEcCtD
Solifenacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000694	0.000694	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.000685	CcSEcCtD
Solifenacin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.000681	CcSEcCtD
Solifenacin—Rash—Etoposide—peripheral nervous system neoplasm	0.000676	0.000676	CcSEcCtD
Solifenacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Solifenacin—Headache—Etoposide—peripheral nervous system neoplasm	0.000671	0.000671	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000667	CcSEcCtD
Solifenacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00065	0.00065	CcSEcCtD
Solifenacin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000642	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000642	0.000642	CcSEcCtD
Solifenacin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Solifenacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000635	0.000635	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000622	0.000622	CcSEcCtD
Solifenacin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Solifenacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000606	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.000602	CcSEcCtD
Solifenacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Solifenacin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Solifenacin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000594	CcSEcCtD
Solifenacin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000588	CcSEcCtD
Solifenacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Solifenacin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000583	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000556	CcSEcCtD
Solifenacin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000552	0.000552	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Solifenacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000534	CcSEcCtD
Solifenacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Solifenacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000519	0.000519	CcSEcCtD
Solifenacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Solifenacin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Solifenacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000495	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000494	CcSEcCtD
Solifenacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Solifenacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Solifenacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000475	0.000475	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000458	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000455	0.000455	CcSEcCtD
Solifenacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Solifenacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000431	0.000431	CcSEcCtD
Solifenacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000425	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.00041	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Solifenacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000393	CcSEcCtD
Solifenacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Solifenacin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Solifenacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Solifenacin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Solifenacin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Solifenacin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Solifenacin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00033	CcSEcCtD
